José Miguel
González-Moro Rodríguez
Profesor/a Asociado/a en CC. de la Salud


PharmaMar
Madrid, EspañaPublications in collaboration with researchers from PharmaMar (1)
2019
-
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome
Hematological Oncology, Vol. 37, Núm. 1, pp. 96-102